Biomatics Capital

eGenesis adds Daniel Lynch to its Board as Executive Chairman along with raising $38m Series A financing led by Biomatics Capital and ARCH Venture Partners

– USA, MA – eGenesis, a biotechnology company focused on utilizing genome editing technology to make xenotransplantation a routine and lifesaving medical procedure, today announced that it raised a $38 million Series A financing co-led by Biomatics Capital and ARCH Venture Partners, with participation from Khosla Ventures, Alta Partners, Alexandria Venture Investments, Heritage Provider Network, Berggruen Holdings North America Ltd., Uprising, and Fan Ventures.… => Read more

Aledade announces Julie Sunderland to its Board along with raising $20m funding led by Biomatics Capital

– USA, MD – Aledade, Inc., a national leader in value-based care, today announced it raised an additional $20 million in funding.… => Read more